Trademark Overview
On Friday, May 17, 2024, a trademark application was filed for ENIGMA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ENIGMA THERAPEUTICS trademark a serial number of 98556226. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 10, 2025. This trademark is owned by Enigma Therapeutics Ltd.. The ENIGMA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders; pharmaceutical compositions for the treatment of autoimmune diseases and disorders; biotechnological preparations for medical use for the treatment of oncological diseases and disorders; biotechnological preparations for medical use for the treatment of autoimmune diseases and disorders; biotechnological preparations for the treatment of oncological diseases and disorders; biotechnological preparations for the treatment of autoimmune diseases and disorders; antibodies for veterinary use; antibodies for medical use; pharmaceutical preparations containing antigens for the treatment of oncological diseases and disorders; pharmaceutical preparations containing antigens for the treatment of autoimmune diseases a...
Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development services; pharmaceutical research; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; structural and functional analysis of genomes; genetic testing for scientific research; research and development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy and therapeutics; research and development services in the field of antibodies and antigens; technological services, namely, scientific research in the field of pharmaceuticals; technological services, namely, analysis in the field of pharmaceuticals; technological services, namely, testing in the field of pharmaceuticals; laboratory research services relating to the production of monoclonal antibodies; technological services,...
